Biomea Fusion, Inc.
BMEA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840439
No open-market purchases or sales by Biomea Fusion, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Biomea Fusion, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 108
- +20 vs. Q3 2024
- Shares held
- 23.0M
- −429.9K (−1.8%) vs. Q3 2024
- Total value
- $89.3M
- −$147.5M (−62.3%) vs. Q3 2024
- New holders
- 32
- 29 more added
- Sold out
- 12
- 28 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMEA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $36.8M |
| Q1 2026 | 65 | $37.2M |
| Q4 2025 | 60 | $28.8M |
| Q3 2025 | 73 | $50.6M |
| Q2 2025 | 87 | $51.7M |
| Q1 2025 | 95 | $45.0M |
| Q4 2024 | 108 | $89.3M |
| Q3 2024 | 88 | $236.7M |
| Q2 2024 | 107 | $106.1M |
| Q1 2024 | 104 | $465.9M |
| Q4 2023 | 100 | $405.1M |
| Q3 2023 | 85 | $414.5M |
| Q2 2023 | 90 | $649.4M |
| Q1 2023 | 73 | $727.0M |
| Q4 2022 | 55 | $122.0M |
| Q3 2022 | 50 | $144.5M |
| Q2 2022 | 42 | $204.0M |
| Q1 2022 | 50 | $81.2M |
| Q4 2021 | 49 | $127.3M |
| Q3 2021 | 39 | $204.5M |
| Q2 2021 | 44 | $253.9M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Biomea Fusion, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 604,147 | $2.34M | 0.00% | +2,668+0.4% | Added |
| State Street Corp | 604,364 | $2.34M | 0.00% | −36,831−5.7% | Reduced |
| Aisling Capital Management LP | 798,757 | $3.10M | 1.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,401,113 | $5.44M | 0.00% | +3,216+0.2% | Added |
| Baker Bros. Advisors LP | 1,451,990 | $5.63M | 0.06% | −656,959−31.2% | Reduced |
| BlackRock, Inc. | 2,219,296 | $8.61M | 0.00% | −77,297−3.4% | Reduced |
| Cormorant Asset Management, LP | 3,570,872 | $13.9M | 0.76% | 00.0% | Unchanged |
| FMR LLC | 5,435,803 | $21.1M | 0.00% | +4,278+0.1% | Added |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −83,554−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −40,477−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −19,553−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −16,701−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −16,302−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −11,629−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −2,025−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −1,036−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −2−100.0% | Sold out |